340 related articles for article (PubMed ID: 34154405)
1. Shared and Unique Evolutionary Trajectories to Ciprofloxacin Resistance in Gram-Negative Bacterial Pathogens.
Zlamal JE; Leyn SA; Iyer M; Elane ML; Wong NA; Wamsley JW; Vercruysse M; Garcia-Alcalde F; Osterman AL
mBio; 2021 Jun; 12(3):e0098721. PubMed ID: 34154405
[TBL] [Abstract][Full Text] [Related]
2. The Landscape of Phenotypic and Transcriptional Responses to Ciprofloxacin in Acinetobacter baumannii: Acquired Resistance Alleles Modulate Drug-Induced SOS Response and Prophage Replication.
Geisinger E; Vargas-Cuebas G; Mortman NJ; Syal S; Dai Y; Wainwright EL; Lazinski D; Wood S; Zhu Z; Anthony J; van Opijnen T; Isberg RR
mBio; 2019 Jun; 10(3):. PubMed ID: 31186328
[TBL] [Abstract][Full Text] [Related]
3. Experimental evolution in morbidostat reveals converging genomic trajectories on the path to triclosan resistance.
Leyn SA; Zlamal JE; Kurnasov OV; Li X; Elane M; Myjak L; Godzik M; de Crecy A; Garcia-Alcalde F; Ebeling M; Osterman AL
Microb Genom; 2021 May; 7(5):. PubMed ID: 33945454
[TBL] [Abstract][Full Text] [Related]
4. Two Classes of DNA Gyrase Inhibitors Elicit Distinct Evolutionary Trajectories Toward Resistance in Gram-Negative Pathogens.
Leyn SA; Kent JE; Zlamal JE; Elane ML; Vercruysse M; Osterman AL
bioRxiv; 2023 Sep; ():. PubMed ID: 37425702
[TBL] [Abstract][Full Text] [Related]
5. Parallel Evolution of Tobramycin Resistance across Species and Environments.
Scribner MR; Santos-Lopez A; Marshall CW; Deitrick C; Cooper VS
mBio; 2020 May; 11(3):. PubMed ID: 32457248
[TBL] [Abstract][Full Text] [Related]
6. Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli.
Huseby DL; Pietsch F; Brandis G; Garoff L; Tegehall A; Hughes D
Mol Biol Evol; 2017 May; 34(5):1029-1039. PubMed ID: 28087782
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
Lee JK; Lee YS; Park YK; Kim BS
Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
[TBL] [Abstract][Full Text] [Related]
8. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
[TBL] [Abstract][Full Text] [Related]
9. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
[TBL] [Abstract][Full Text] [Related]
10. [Mutations in gyrA and gyrB genes among strains of Gram-negative bacilli isolated from Chilean hospitals and their relation with resistance to fluoroquinolones].
De la Fuente C M; Dauros S P; Bello T H; Domínguez Y M; Mella M S; Sepúlveda A M; Zemelman Z R; González R G
Rev Med Chil; 2007 Sep; 135(9):1103-10. PubMed ID: 18064363
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
12. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
Lei YC; Wang HB; Sun ZY; Shen ZY
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
14. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
Bansal S; Tandon V
Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem.
Rehman A; Patrick WM; Lamont IL
J Med Microbiol; 2019 Jan; 68(1):1-10. PubMed ID: 30605076
[TBL] [Abstract][Full Text] [Related]
16. Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010.
Nam YS; Cho SY; Yang HY; Park KS; Jang JH; Kim YT; Jeong JW; Suh JT; Lee HJ
Int J Antimicrob Agents; 2013 Feb; 41(2):126-9. PubMed ID: 23265914
[TBL] [Abstract][Full Text] [Related]
17. Detection of ciprofloxacin resistance in gram-negative bacteria due to alterations in gyrA.
Power EG; Muñoz Bellido JL; Phillips I
J Antimicrob Chemother; 1992 Jan; 29(1):9-17. PubMed ID: 1310671
[TBL] [Abstract][Full Text] [Related]
18. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
[No Abstract] [Full Text] [Related]
19. Insertion sequence disruption of adeR and ciprofloxacin resistance caused by efflux pumps and gyrA and parC mutations in Acinetobacter baumannii.
Lopes BS; Amyes SG
Int J Antimicrob Agents; 2013 Feb; 41(2):117-21. PubMed ID: 23217848
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.
Montanari MP; Tili E; Cochetti I; Mingoia M; Manzin A; Varaldo PE
Microb Drug Resist; 2004; 10(3):209-17. PubMed ID: 15383164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
